Yu Hongjin-SHENZHEN PRO HITU MEDICAL CO., LTD.

Non-Invasive Treatment Expert Perspectives

Yu Hongjin

Chief Physician, Specialist

Dr. Yu has been practicing obstetrics and gynecology for 30 years and is skilled in the minimally invasive surgical treatment of various benign and malignant gynecologic tumors, endometriosis and cesarean scar pregnancy. She also specializes in the diagnosis, treatment and long-term management of various gynecological endocrine diseases, menstrual disorders and menopausal syndromes.

Expert opinion

1. We now have a new concept of “surgical treatment”. The transition from traditional laparotomy to non-invasive treatment is a medical revolution. We are all striving to make further progress.

2. In addition to benign gynecologic diseases, non-invasive treatment techniques are often used for the treatment or palliative care of malignant tumors. This type of treatment can often produce good results.

3. After three months of treatment of uterine fibroids with this technique, the volume of fibroids can reduce by 1 to 1.5 cm. Most patients can also experience a significant reduction in menstrual flow.

4. A total of 600 patients have been treated, with an effective rate of 85% and a rate of uterine fibroid volume reduction of 47.6%.

5. Having received non-invasive HIFU therapy, patients can recover quickly and can be treated repeatedly.

6. Early treatment can inhibit the continuous growth of the lesion to reduce the need for surgery.

7. This technology can reduce the rate of hysterectomy and preserve the pelvic floor organs and functional integrity.

2019 Dongguan Gynecology Annual Conference

Director Yu Hongjin- the Application of High-Intensity Focused Ultrasound for Benign Uterine Diseases.

We now have a new concept of “surgical treatment”. The upgrade from traditional laparotomy to non-invasive treatment is a medical revolution. We are all striving to make further progress.

In addition to benign gynecologic diseases, non-invasive treatment techniques are often used for the treatment or palliative care of malignant tumors. This type of treatment can often produce good results.

After three months of treatment of uterine fibroids with this technique, the volume of fibroids can reduce by 1 to 1.5 cm. Most patients can also experience a significant reduction in menstrual flow.

A total of 600 patients have been treated, with an effective rate of 85% and a rate of uterine fibroid volume reduction of 47.6%.

Having received non-invasive HIFU therapy, patients can recover quickly and can be treated repeatedly.

Early treatment can inhibit the continuous growth of the lesion to reduce the need for surgery.

This technology can reduce the rate of hysterectomy and preserve the pelvic floor organs and functional integrity.